UBE2C and lung carcinoma: Since UBE2C-autophagy repression axis is evolutionarily deregulated in NSCLC and serves as a potential druggable target in lung cancer treatment, we phenotypically analyzed the consequences resulting from dysregulation of UBE2C-autophagy repression axis in lung cancer cells.